◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › O › OFIX

Orthofix Medical Inc (OFIX) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-10-05

Orthofix Medical Inc (OFIX) operates in the MEDICAL DEVICES industry and is headquartered in Lewisville, United States with about 1,605 employees. Its market capitalization is roughly $369 million. In the fiscal year ended 2025-12-31, OFIX reported $822M in revenue and ($92M) in net income.

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction.

Interactive charts & full statements → Open the OFIX valuation workbench →

OFIX Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$833M	$822M	$799M	$747M	$461M	$464M	$407M	$460M	$453M	$434M	$410M	$396M	$402M	$401M	$462M	$579M	$564M	$546M	$520M	$490M	$365M
Gross Profit	$580M	$552M	$546M	$486M	$337M	$350M	$305M	$359M	$356M	$341M	$322M	$310M	$303M	$298M	$376M	$440M	$433M	$407M	$368M	$361M	$272M
Gross Margin %	69.6%	67.1%	68.3%	65.1%	73.2%	75.3%	74.9%	78.1%	78.7%	78.5%	78.6%	78.2%	75.4%	74.5%	81.3%	76.0%	76.7%	74.6%	70.8%	73.7%	74.4%
Operating Income (EBIT)	($25M)	($68M)	($85M)	($139M)	($13M)	($8M)	($6M)	($19M)	$30M	$41M	$21M	$9M	$17M	($5M)	$89M	$33M	$89M	$64M	($257M)	$38M	$9M
Operating Margin %	-3.0%	-8.3%	-10.6%	-18.6%	-2.9%	-1.8%	-1.5%	-4.1%	6.6%	9.4%	5.1%	2.3%	4.3%	-1.3%	19.2%	5.6%	15.8%	11.7%	-49.4%	7.8%	2.4%
Net Income	($62M)	($92M)	($126M)	($151M)	($20M)	($38M)	$3M	($28M)	$14M	$6M	$3M	($3M)	($9M)	($28M)	$51M	($1M)	$44M	$24M	($229M)	$11M	($7M)
Net Margin %	-7.4%	-11.2%	-15.8%	-20.3%	-4.3%	-8.3%	0.6%	-6.2%	3.0%	1.4%	0.8%	-0.7%	-2.1%	-7.1%	11.1%	-0.2%	7.8%	4.5%	-44.0%	2.2%	-1.9%
EBITDA	$107M	($22M)	($34M)	($79M)	$16M	$21M	$36M	$2M	$42M	$61M	$40M	$30M	$41M	$14M	$96M	$53M	$112M	$87M	($244M)	$70M	$26M
Earnings Per Share (EPS)	$-1.53	$-2.31	$-3.30	$-4.12	$-0.98	$-1.95	$0.13	$-1.51	$0.73	$0.34	$0.17	$-0.15	$-0.46	$-1.52	$2.65	$-0.06	$2.47	$1.42	$-13.37	$0.64	$-0.44
Shares Outstanding (M)	41M	40M	38M	37M	20M	20M	19M	19M	19M	18M	18M	19M	18M	19M	19M	18M	18M	17M	17M	17M	16M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OFIX Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$211M	$197M	$220M	$206M	$203M	$194M	$216M	$197M
Gross Profit	$150M	$140M	$142M	$149M	$140M	$122M	$149M	$135M
Gross Margin %	71.0%	70.9%	64.6%	72.2%	68.7%	62.8%	69.0%	68.7%
Operating Income (EBIT)	($8M)	($14M)	$13M	($17M)	($16M)	($49M)	($11M)	($19M)
Operating Margin %	-3.9%	-7.0%	6.1%	-8.3%	-7.9%	-25.2%	-5.3%	-9.6%
Net Income	($16M)	($21M)	($2M)	($23M)	($14M)	($53M)	($29M)	($27M)
Net Margin %	-7.5%	-10.6%	-1.0%	-11.1%	-6.9%	-27.4%	-13.5%	-13.9%
EBITDA	$20M	($2M)	$92M	($3M)	$8M	($12M)	$13M	($5M)
Earnings Per Share (EPS)	$-0.39	$-0.52	$-0.06	$-0.57	$-0.36	$-1.35	$-0.75	$-0.71
Shares Outstanding (M)	41M	40M	40M	40M	40M	39M	39M	38M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OFIX Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$17M	$33M	$26M	($46M)	($12M)	$18M	$74M	$32M	$50M	$53M	$45M	$43M	$51M	$67M	$11M	$65M	$42M	$50M	$27M	$21M	$8M
Capital Expenditures (CapEx)	$44M	$35M	$35M	$62M	$23M	$20M	$17M	$21M	$15M	$17M	$18M	$28M	$19M	$30M	$29M	$26M	$26M	$22M	$20M	$27M	$13M
Free Cash Flow (FCF)	($27M)	($1M)	($9M)	($108M)	($35M)	($1M)	$57M	$12M	$35M	$36M	$26M	$15M	$32M	$37M	($18M)	$39M	$16M	$28M	$7M	($6M)	($4M)
FCF Margin %	-3.2%	-0.2%	-1.1%	-14.4%	-7.5%	-0.2%	14.1%	2.5%	7.6%	8.4%	6.4%	3.9%	8.1%	9.3%	-3.8%	6.7%	2.9%	5.1%	1.3%	-1.2%	-1.2%
Dividends Paid	—	—	—	—	$2M	$3M	$2M	$5M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	—	$0M	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OFIX Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	($6M)	($18M)	$28M	$12M	$12M	($18M)	$24M	$12M
Capital Expenditures (CapEx)	$13M	$11M	$11M	$10M	$7M	$7M	$9M	$6M
Free Cash Flow (FCF)	($19M)	($28M)	$18M	$2M	$5M	($25M)	$15M	$6M
FCF Margin %	-8.9%	-14.4%	8.0%	1.2%	2.2%	-13.0%	7.0%	3.0%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

OFIX Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$873M	$851M	$893M	$925M	$459M	$477M	$526M	$496M	$467M	$405M	$372M	$400M	$393M	$427M	$504M	$696M	$604M	$590M	$561M	$886M	$862M
Cash & Cash Equivalents	$104M	$82M	$83M	$33M	$51M	$88M	$96M	$70M	$70M	$81M	$40M	$64M	$37M	$30M	$31M	$33M	$14M	$13M	$15M	$25M	$26M
Total Liabilities	$444M	$401M	$390M	$327M	$122M	$140M	$169M	$168M	$131M	$109M	$109M	$110M	$94M	$116M	$105M	$380M	$303M	$350M	$359M	$452M	$470M
Total Debt (Short + Long-Term)	$222M	$161M	$162M	$99M	$2M	$4M	$3M	$2M	$0M	$0M	$0M	$0M	$0M	$20M	$20M	$210M	$220M	$255M	$283M	$307M	$315M
Total Shareholders' Equity	$429M	$450M	$503M	$599M	$337M	$337M	$357M	$328M	$335M	$297M	$263M	$290M	$300M	$311M	$399M	$315M	$301M	$240M	$202M	$434M	$393M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OFIX viewer.

Other Companies in MEDICAL DEVICES

CERS · Cerus Corporation — $472 million
SSII · SS Innovations International Inc. Common Stock — $467 million
BWAY · Brainsway Ltd — $449 million
NPCE · Neuropace Inc — $422 million
CLPT · Clearpoint Neuro Inc — $342 million
PHG · Koninklijke Philips NV ADR — $28 billion
GKOS · Glaukos Corp — $14 billion
SNN · Smith & Nephew SNATS Inc — $13 billion

← OFIUS All “O” companies OFLX →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.